Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study

Author:

Känzig TanjaORCID,Potterat Melisa,Corpataux Thibault,Ackermann Simone Daniele,Chaix Edouard,Gibilisco Andrea,Portmann Aurelia,Roberts Judith,Schaller Amandine,Wenger Nicolas,Wolffers Oliver,Beguelin Charles,Genne Daniel

Abstract

ObjectivesThe aim of the study was to analyse the proportion of evidence-based medication displayed in pharmacies and compare it between the different linguistic regions of the country, at different times of the year to determine the amount of proven effective medications indirectly recommended to the public in different parts of Switzerland.DesignThis is an observational study conducted by medical doctors in the department of internal medicine at the Spitalzentrum Biel, Switzerland.SettingThe observation took place from July 2019 to May 2020. From a total of 1800 pharmacies in Switzerland, 68 different pharmacies were selected across the 3 main linguistic regions and the medication on display in their windows were examined 4 times a year regarding their efficacy. The displays of medication with or without evidence-based efficacy were described using absolute numbers and proportions and compared between the different linguistic regions at different seasons using χ2.ParticipantsThere were no human or animal participants involved in this study.Primary and secondary outcome measuresThe primary outcome is the proportion of medication displayed in pharmacy windows with a proven effectiveness in medical literature. The secondary outcome was the variability of the primary outcome over time (seasonal changes), over the different linguistic regions of Switzerland and between chains and privately owned pharmacies.ResultsWe examined 970 medications and found that over the whole year, there is a high proportion of non-evidence-based drugs (56,9%) displayed in pharmacies. Swiss German cantons display significantly more non-evidence-based medications in winter. We found no statistical difference for other seasons or between chains and privately owned pharmacies.ConclusionPharmacies in Switzerland tend to display significantly more non-evidence-based drugs, thus indirectly recommending them to the public. In a time of necessary expansion of self-medication by the population, this could incite consumers to buy drugs without proven effectiveness.

Publisher

BMJ

Subject

General Medicine

Reference26 articles.

1. Abgabekategorien von Arzneimittel . Pharmasuisse. 2019. Available: https://www.pharmasuisse.org/data/docs/de/9087/Abgabekategorien-von-Arzneimitteln.pdf?v=1.0 [Accessed Jun 2023].

2. Mitteilung von Swissmedic Bezüglich Umteilung der Abgabekategorien. 2018. Available: https://www.swissmedic.ch/swissmedic/de/home/news/mitteilungen/hmg2-umteilung-arzneimittel-abgabekategorie-c.html [Accessed Jun 2023].

3. Simplified provision of list B medicinal products. 2023. Available: https://www.bag.admin.ch/bag/en/home/medizin-und-forschung/heilmittel/abgabe-von-arzneimitteln.html#815451004 [Accessed Jun 2023].

4. Federal act on medicinal products and medical devices. 2022. Available: https://www.admin.ch/opc/de/classified-compilation/20002716/index.html [Accessed Jun 2023].

5. Legislation governing therapeutic products in Switzerland. 2023. Available: https://www.fedlex.admin.ch/eli/cc/2018/588/de

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3